Terapet
Terapet is a Geneva-based CERN spin-off Medtech company that develops and manufactures nuclear imaging systems for real-time dose verification and monitoring during proton therapy and other cancer treatments, serving hospitals and cancer treatment centers.
- Company typePrivate
- Founded2019
- HeadquartersGeneva, Switzerland
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Terapet does
Terapet is a Geneva-based Swiss Medtech company spun out of CERN, founded in 2019, that develops and manufactures nuclear imaging systems for radiation oncology. The company's technology focuses on real-time, in-vivo dose verification and monitoring during cancer treatment, with a primary application in proton therapy where precise dose delivery is critical to treatment efficacy and patient safety.
Terapet's product portfolio comprises two distinct offerings. Qualγscan is the company's first commercial product, a nuclear imaging device designed for real-time dose monitoring during cancer treatment and for validation of radiation doses delivered to patients; it is positioned as Terapet's anchor commercial offering with regulatory clearance pathway for the healthcare sector. TheraVivo is an in-development in-vivo proton therapy dose verification project funded in part by a Eurostars grant, extending the platform toward next-generation particle therapy imaging workflows. Underlying both is proprietary nuclear imaging technology leveraging the founders' CERN physics lineage.
The company sells to cancer treatment centers and hospitals running proton therapy programs, addressing pain points around treatment accuracy verification and reduction of side effects from radiation mis-dosing. Terapet is privately held and venture-backed, having raised a cumulative disclosed total of approximately $14.9 million across nine funding events between 2019 and 2026 from venture investors (EFI Lake Geneva Ventures, Nina Capital, FONGIT, Venture Kick) and non-dilutive Swiss deep-tech grants (Innosuisse, Eurostars). The organization operates with 11–50 employees and is headquartered in Geneva, Switzerland; revenue and pricing are not publicly disclosed.
Terapet firmographics
Firmographics- Name
- Terapet
- Legal name
- Terapet
- Website
- https://terapet.ch
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Terapet is a Geneva-based CERN spin-off Medtech company that develops and manufactures nuclear imaging systems for real-time dose verification and monitoring during proton therapy and other cancer treatments, serving hospitals and cancer treatment centers.
- Ownership category
- akta.pro rank
Terapet industry classification
Industry- Product category
- Medical Imaging Equipment
- NAICS
- Irradiation Apparatus Manufacturing (334517), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844), Laboratory Analytical Instruments (3826), Industrial Instruments For Measurement, Display, And Control (3823)
- akta.pro primary industry
- Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim) (HLAHABAH)
- akta.pro secondary industry
- Radiation Oncology (HLAKAFAC)
Keywords
Where Terapet is headquartered
LocationHeadquarters
- HQ city
- Geneva
- HQ country
- Switzerland
- HQ region
- Europe
Markets served
Terapet business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales
Terapet product offering
Product offeringCore offering
Terapet develops and manufactures nuclear imaging systems used for real-time dose monitoring during cancer treatment. Its first commercial product, Qualγscan, provides quality gamma scanning to validate and monitor radiation doses delivered during particle therapy. The TheraVivo project extends this capability to in-vivo proton therapy dose verification, targeting precision oncology workflows at clinical sites.
Product overview
Terapet is a Swiss Medtech company offering nuclear imaging products for radiation therapy applications. The company has a portfolio consisting of its first commercial product, Qualγscan, which provides real-time dose monitoring during cancer treatment, and an emerging product development project called TheraVivo focused on in-vivo proton therapy dose verification. The two products address different aspects of nuclear imaging in cancer treatment—Qualγscan is the currently commercialized offering while TheraVivo represents next-generation technology for proton therapy verification.
Differentiator
Problem solved
Functional benefit
Brands
- Qualγscan: First commercialized nuclear imaging product by Terapet for quality gamma scanning applications.
- TheraVivo
Products and services
- Qualγscan Nuclear imaging system designed for real-time dose monitoring during cancer treatment. It enables quality gamma scanning to validate and monitor radiation doses delivered to patients during particle therapy, and is intended for cancer treatment centers and hospitals.
- TheraVivo In-vivo proton therapy dose verification technology developed to provide real-time, in-vivo monitoring of radiation dose delivery during proton therapy. It is targeted at clinical oncology settings using particle therapy.
Companies that use Terapet
Customer profileSegments1 record
Ideal customer profiles1 record
Terapet technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Terapet partnerships and signals
Strategic signalScale indicators2 records
Recent moves5 records
Expansion highlights4 records
Terapet competitors and assessment
Company assessmentBroad incumbents
- GE HealthCare: Major medical imaging and diagnostics OEM including nuclear medicine (SPECT/PET) and oncology solutions. Broadly comparable as a large incumbent with overlapping clinical buyer relationships and the capacity to enter adjacent niches like proton therapy verification.
- Siemens Healthineers: Global medical imaging OEM with SPECT/CT, PET/CT, and radiation oncology offerings. Relevant as a potential competitor and as the dominant installed base of nuclear imaging systems that Terapet would either complement or displace.
- Philips Healthcare: Global health technology company with diagnostic imaging, image-guided therapy, and oncology portfolios. Comparable as a broad incumbent whose radiation oncology and nuclear medicine footprint overlaps with Terapet's clinical target market.
Direct peers
- Sun Nuclear (Mirion Medical): Provides patient QA and dosimetry solutions for radiation therapy including proton therapy. Closely comparable to Terapet as both deliver quality assurance and dose verification hardware/software for radiation oncology workflows.
- Standard Imaging: US-based manufacturer of radiation therapy QA and dosimetry instruments used in proton and photon therapy centers. Direct comparable given overlapping product categories (detectors, phantoms, QA software) serving the same clinical end users.
- PTW Freiburg: German specialist in radiation dosimetry and detector technology for medical physics. Comparable because PTW supplies the detectors, phantoms, and QA systems used alongside proton therapy delivery — directly adjacent to Terapet's nuclear imaging platform.
- Modus Medical Devices: Canadian manufacturer of QA phantoms, software, and dose verification tools for radiation therapy. Closely comparable to Terapet at the radiation therapy QA product level, serving the same hospital medical physics teams.
- IBA (Ion Beam Applications): Belgian leader in proton therapy systems and radioisotopes. IBA is directly comparable because it both supplies proton therapy equipment and offers dosimetry/QA solutions, operating in the same clinical workflow that Terapet addresses.
- Mediso Medical Imaging Systems: Hungarian manufacturer of SPECT, PET, and hybrid nuclear imaging systems for preclinical and clinical use. Comparable as a specialized nuclear imaging hardware vendor serving research and clinical nuclear medicine buyers that overlap with Terapet's customer profile.
Emerging players
- Mevion Medical Systems: US-based compact proton therapy system manufacturer. Comparable as a focused player in proton therapy delivery; overlaps with Terapet at the clinical buyer level (proton centers) but does not address dose verification imaging.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Terapet social profiles
Digital presenceTerapet financial estimates
Financial estimateRevenue estimate
Valuation estimate
Terapet leadership team
Management profileNumber of profiles
Profiles3 records
Terapet funding detail
Funding detailFunding overview
Funding rounds9 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Terapet M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Terapet
What does Terapet do?
Terapet develops and manufactures nuclear imaging systems used for real-time dose monitoring during cancer treatment. Its first commercial product, Qualγscan, provides quality gamma scanning to validate and monitor radiation doses delivered during particle therapy. The TheraVivo project extends this capability to in-vivo proton therapy dose verification, targeting precision oncology workflows at clinical sites.
Is Terapet a public or private company?
Terapet is a private company. It is classified as venture growth investor backed and is currently operating.
When was Terapet founded?
Terapet was founded in 2019. It employs 11 to 50 people.
Where is Terapet based?
Terapet is headquartered in Geneva, Switzerland, in the Europe region.
Who are Terapet's main competitors?
Broad incumbents on record are GE HealthCare, Siemens Healthineers and Philips Healthcare. Direct peers are Sun Nuclear (Mirion Medical), Standard Imaging, PTW Freiburg, Modus Medical Devices, IBA (Ion Beam Applications) and Mediso Medical Imaging Systems. Mevion Medical Systems is listed as an emerging player.
Does Terapet have an API?
No public API is recorded for Terapet.
What industry is Terapet in?
Terapet's product category is Medical Imaging Equipment. Its primary akta.pro industry code is HLAHABAH, Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim), with a secondary code of HLAKAFAC, Radiation Oncology. Its NAICS code is 334517 and its SIC code is 3844.